GPER1 and breast carcinoma: IHC on samples from our cohort and commercial TMA showed predominantly cytoplasmic staining for GPER, with a perinuclear accentuation, which supports its localization in the endoplasmic reticulum and/or cellular membrane, as reported for breast cancer [62].